---
phase: 15-validation-and-acceptance-closure
verified: 2026-04-02T15:18:14Z
status: passed
score: 3/3 must-haves verified
re_verification:
  previous_result: had_gaps
  previous_score: 2/3
  gaps_closed:
    - "VAL-03 contract is now explicitly deferred-traceability (not execution) and is fully evidenced across validation/summary/checkpoint artifacts."
  gaps_remaining: []
  regressions: []
---

# Phase 15: Validation & Acceptance Closure Verification Report

**Phase Goal:** v1.2 ships with verification evidence, reference examples, and platform validation records.  
**Verified:** 2026-04-02T15:18:14Z  
**Status:** passed  
**Re-verification:** Yes — after contract alignment and gap closure

## Goal Achievement

### Observable Truths

| # | Truth | Status | Evidence |
| --- | --- | --- | --- |
| 1 | Project ships example sketch/script case studies, including constraint-focused samples. | ✓ VERIFIED | Three case-study folders exist with runbooks + scripts under `evidence/case-studies/` (`sketch-01-constraint-debug`, `sketch-02-driven-dimensions`, `script-io-scenario-01-parse-apply-reset-diagnostics`). |
| 2 | v1.2 feature acceptance gates pass on Windows MSVC + Vulkan. | ✓ VERIFIED | `evidence/windows-vulkan-msvc/gate-build-mdcad.txt` contains command, build anchor, `ExitCode: 0`; `gate-ctest-full.txt` contains command, `100% tests passed`, `ExitCode: 0`; provenance present in `provenance.md`. |
| 3 | macOS parity validation deferment is explicitly recorded after Windows gate pass with follow-up handoff (Phase 15 contract). | ✓ VERIFIED | `15-VALIDATION.md` VAL-03 section explicitly states deferred/out-of-scope + handoff; mirrored in `15-03-SUMMARY.md` and `CHECKPOINT.md` continuity entry. |

**Score:** 3/3 truths verified

### Required Artifacts

| Artifact | Expected | Status | Details |
| --- | --- | --- | --- |
| `.planning/phases/15-validation-and-acceptance-closure/evidence/case-studies/*` | 2 sketch + 1 Script IO scenario artifacts | ✓ VERIFIED | All required folders/files present; READMEs include repro steps, expected outcomes, diagnostics; scripts present. |
| `.planning/phases/15-validation-and-acceptance-closure/evidence/windows-vulkan-msvc/gate-build-mdcad.txt` | Windows build evidence | ✓ VERIFIED | Contains exact build command, `mdCAD.vcxproj` output anchor, and `ExitCode: 0`. |
| `.planning/phases/15-validation-and-acceptance-closure/evidence/windows-vulkan-msvc/gate-ctest-full.txt` | Windows ctest evidence | ✓ VERIFIED | Contains exact ctest command, pass anchor, and `ExitCode: 0`. |
| `.planning/phases/15-validation-and-acceptance-closure/evidence/windows-vulkan-msvc/provenance.md` | Provenance metadata | ✓ VERIFIED | Includes timestamp, source commit, command identity, evidence file linkage. |
| `.planning/phases/15-validation-and-acceptance-closure/15-VALIDATION.md` | Requirement mapping for VAL-01..VAL-03 per accepted contract | ✓ VERIFIED | Explicit VAL-01/02 evidence mapping and VAL-03 deferred-traceability contract with handoff note. |
| `.planning/phases/15-validation-and-acceptance-closure/15-03-SUMMARY.md` | Closure narrative with VAL-03 deferment trace | ✓ VERIFIED | Records deferred status + no completion claim + follow-up path. |
| `CHECKPOINT.md` | Continuity entry mirroring closure outcomes | ✓ VERIFIED | Phase 15 section includes case-study package, Windows gates, and VAL-03 deferred handling. |

### Key Link Verification

| From | To | Via | Status | Details |
| --- | --- | --- | --- | --- |
| `15-VALIDATION.md` | `evidence/case-studies/*` | Explicit artifact path references | ✓ WIRED | All three case-study folders and script files are referenced in VAL-01 mapping. |
| `15-VALIDATION.md` | `evidence/windows-vulkan-msvc/gate-build-mdcad.txt` | VAL-02 evidence linkage | ✓ WIRED | Build evidence path and anchors are explicitly linked. |
| `15-VALIDATION.md` | `evidence/windows-vulkan-msvc/gate-ctest-full.txt` | VAL-02 evidence linkage | ✓ WIRED | CTest evidence path and anchors are explicitly linked. |
| `15-VALIDATION.md` | `15-03-SUMMARY.md` + `CHECKPOINT.md` | VAL-03 deferred traceability anchors | ✓ WIRED | VAL-03 section explicitly names both downstream closure artifacts. |
| `15-03-SUMMARY.md` | `CHECKPOINT.md` | Mirrored deferred/handoff wording | ✓ WIRED | Deferred/out-of-scope phrasing and follow-up intent are consistent. |

### Data-Flow Trace (Level 4)

| Artifact | Data Variable | Source | Produces Real Data | Status |
| --- | --- | --- | --- | --- |
| Documentation/evidence artifacts | N/A | N/A | N/A | N/A (phase outputs are static evidence/docs, not runtime dataflow components) |

### Behavioral Spot-Checks

| Behavior | Command | Result | Status |
| --- | --- | --- | --- |
| Case-study composition exists | `Get-ChildItem .../evidence/case-studies -Directory` | 3 required scenario directories found | ✓ PASS |
| Windows build gate evidence is concrete | `Select-String gate-build-mdcad.txt '(Command|mdCAD.vcxproj|ExitCode: 0)'` | 3 anchor hits | ✓ PASS |
| Windows ctest gate evidence is concrete | `Select-String gate-ctest-full.txt '(Command|100% tests passed|ExitCode: 0)'` | 3 anchor hits | ✓ PASS |
| Deferred traceability is present across closure artifacts | `Select-String 15-VALIDATION.md,15-03-SUMMARY.md,CHECKPOINT.md 'VAL-03|deferred|out of scope|follow-up'` | Hits present in all three files | ✓ PASS |

### Requirements Coverage

| Requirement | Source Plan | Description | Status | Evidence |
| --- | --- | --- | --- | --- |
| VAL-01 | 15-01-PLAN.md | Example sketch/script case studies shipped | ✓ SATISFIED | Required 2 sketch + 1 Script IO artifacts exist with runbooks and scripts; mapped in `15-VALIDATION.md`. |
| VAL-02 | 15-02-PLAN.md | Windows MSVC + Vulkan acceptance gates pass | ✓ SATISFIED | Build and full ctest command outputs captured with explicit success anchors and `ExitCode: 0`. |
| VAL-03 | 15-03-PLAN.md | Deferred-traceability completion for macOS parity status in Phase 15 | ✓ SATISFIED | Deferred/out-of-scope + no completion claim + follow-up handoff explicitly documented in validation, summary, and checkpoint artifacts. |

### Anti-Patterns Found

| File | Line | Pattern | Severity | Impact |
| --- | --- | --- | --- | --- |
| `.planning/phases/15-validation-and-acceptance-closure/15-03-SUMMARY.md` | 52-53 | `pending (to be committed in wave 3)` placeholders in task commit list | ℹ️ Info | Documentation bookkeeping only; does not block acceptance contract evidence. |

### Human Verification Required

None blocking phase acceptance contract. (Interactive reproducibility of case studies remains useful for UAT but is outside this contract re-verification pass.)

### Gaps Summary

No contract gaps remain. Under the current accepted Phase 15 contract (VAL-03 = deferred-traceability completion), all three requirements are satisfied with concrete, cross-linked evidence artifacts.

---

_Verified: 2026-04-02T15:18:14Z_  
_Verifier: the agent (gsd-verifier)_
